ClearPoint Neuro Q3 Revenue Jumps 36% to $12.1M; 2026 Guidance Set at $48-50M
CLPT sits 28% above its 52-week low of $8.27.
Summary
ClearPoint Neuro reported Q3 2026 revenue of $12.1 million, up 36%, with neurosurgery navigation and therapy up 59%, and guided full-year 2026 revenue to $48-50 million. Gross margin slipped to 58% and the net loss widened to $7.46 million.
Key Events · Earnings and Guidance · CLPT
-
Q3 Revenue Grows 36% to $12.1M
Total revenue rose to $12.1 million from $8.9 million a year earlier, with neurosurgery navigation and therapy up 59% to $5.4 million and capital equipment and software up 68% to $1.7 million.
-
Gross Margin Slips to 58%
Gross margin fell from 63% to 58%, reflecting overhead at the new ClearPoint Advanced Laboratories facility and added amortization of acquired intangibles; operating expenses rose 23% to $13.4 million.
-
Net Loss Widens to $7.46M
Net loss was $7.46 million, or $0.24 per share, versus $5.89 million, or $0.21 per share, in the prior-year quarter.
-
2026 Guidance Set at $48-50M
Management now estimates full-year 2026 revenue of $48.0 million to $50.0 million, against $37.0 million reported for 2025.
Analysis · CLPT · Industrial Applications And Services
For the first time since the IRRAS acquisition, the growth story is outpacing cost growth: revenue rose 36% to $12.1 million while operating expenses grew 23%, a clear sign of operating leverage. The catch is margin. Gross margin fell to 58% from 63%, weighed down by overhead at the new ClearPoint Advanced Laboratories facility and amortization of acquired intangibles, and the net loss still widened to $7.46 million from $5.89 million. Cash stood at $46.2 million after the company raised $22.0 million through its ATM, giving it runway, but that cash came from selling stock, not operations. The number that will reset expectations is the new 2026 revenue guide of $48-50 million.
How filings like this one have moved
In the 30 days to Oct 29, 2026, 31.1% of the 1661 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CLPT was trading at $10.56 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $322.1M. The 52-week trading range was $8.27 to $27.27. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.